Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06269926 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy

A NA study of Cerebral Palsy and Pain, Chronic, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT06269926 is a NA study of Cerebral Palsy and Pain, Chronic that is active but no longer recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 14 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06269926, a NA study of Cerebral Palsy and Pain, Chronic, is active but no longer recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand if cognitive behavioral therapy can feasibly be provided to groups of adults with cerebral palsy and chronic pain via virtual group therapy sessions.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Chronic Pain

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2025-02-27
Est. Completion 2027-02
Phase NA

What the Registry Record Tells You About NCT06269926

The ClinicalTrials.gov registry entry for NCT06269926 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (94% lower). The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Chronic Pain is the first listed.

NCT06269926 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06269926 about?

NCT06269926 is a clinical study titled "Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy". The purpose of this study is to understand if cognitive behavioral therapy can feasibly be provided to groups of adults with cerebral palsy and chronic pain via virtual group therapy sessions.

What is the current status of trial NCT06269926?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-02-27. Estimated completion is 2027-02.

What conditions does trial NCT06269926 study?

This clinical trial studies the following conditions: Cerebral Palsy, Pain, Chronic.

What interventions are being tested in trial NCT06269926?

The interventions under investigation include: Cognitive Behavioral Therapy for Chronic Pain (BEHAVIORAL).

Who is sponsoring clinical trial NCT06269926?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06269926 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.